Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Nalinie Joharatnam-hogan; Fay Cafferty; Richard Hubner; Daniel Swinson; Sharmila Sothi; Kamalnayan Gupta; Stephen Falk; Kinnari Patel; Nicola Warner; Victoria Kunene; Sam Rowley; Komel Khabra; Tim Underwood; Janusz Jankowski; John Bridgewater; Anne Crossley; Verity Henson; Lindy Berkman; Duncan Gilbert; Howard Kynaston; Alistair Ring; David Cameron; Farhat Din; Janet Graham; Timothy Iveson; Richard Adams; Anne Thomas; Richard Wilson; C S Pramesh; Ruth Langley; John Burn; Sue Campbell; Lisa Capaldi; Yvonne Carse; Durga Gadgil; Arnold Goldman; Sudeep Gupta; Gregory Leonard; Mairead Mackenzie; Mahesh Parmar; Carlo Patrono; Russell Petty; Peter M. Rothwell; Robert J.c. Steele

doi:10.1016/S2468-1253(19)30289-4

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Nalinie Joharatnam-hogan
, Fay Cafferty
, Richard Hubner
, Daniel Swinson
, Sharmila Sothi
, Kamalnayan Gupta
, Stephen Falk
, Kinnari Patel
, Nicola Warner
, Victoria Kunene
, Sam Rowley
, Komel Khabra
, Tim Underwood
, Janusz Jankowski
, John Bridgewater
, Anne Crossley
, Verity Henson
, Lindy Berkman
, Duncan Gilbert
, Howard Kynaston

Alistair Ring, David Cameron, Farhat Din, Janet Graham, Timothy Iveson, Richard Adams, Anne Thomas, Richard Wilson, C S Pramesh, Ruth Langley, John Burn, Sue Campbell, Lisa Capaldi, Yvonne Carse, Durga Gadgil, Arnold Goldman, Sudeep Gupta, Gregory Leonard, Mairead Mackenzie, Mahesh Parmar, Carlo Patrono, Russell Petty, Peter M. Rothwell, Robert J.c. Steele

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	The Lancet Gastroenterology & Hepatology
DOIs	https://doi.org/10.1016/S2468-1253(19)30289-4
Publication status	Published - 30 Aug 2019

Access to Document

10.1016/S2468-1253(19)30289-4

Binder1
This is a pre-copyedited, author-produced version of an article accepted for publication in The Lancet Gastroenterology & Hepatology following peer review. The version of record "Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial" is available online at: https://doi.org/10.1016/S2468-1253(19)30289-4•
Accepted author manuscript, 1.07 MB

https://linkinghub.elsevier.com/retrieve/pii/S2468125319302894

Farhat Din
- Edinburgh Cancer Research Centre
- Institute of Genetics and Cancer
- School of Genetics and Cancer - Personal Chair Bowel Cancer UK Royal College of Surgeons of
Person: Academic: Research Active

Cite this

Joharatnam-hogan, N., Cafferty, F., Hubner, R., Swinson, D., Sothi, S., Gupta, K., Falk, S., Patel, K., Warner, N., Kunene, V., Rowley, S., Khabra, K., Underwood, T., Jankowski, J., Bridgewater, J., Crossley, A., Henson, V., Berkman, L., Gilbert, D., ... Steele, R. J. C. (2019). Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/S2468-1253(19)30289-4

@article{042f62dd7e38470d976a822fbce0689a,

title = "Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial",

author = "Nalinie Joharatnam-hogan and Fay Cafferty and Richard Hubner and Daniel Swinson and Sharmila Sothi and Kamalnayan Gupta and Stephen Falk and Kinnari Patel and Nicola Warner and Victoria Kunene and Sam Rowley and Komel Khabra and Tim Underwood and Janusz Jankowski and John Bridgewater and Anne Crossley and Verity Henson and Lindy Berkman and Duncan Gilbert and Howard Kynaston and Alistair Ring and David Cameron and Farhat Din and Janet Graham and Timothy Iveson and Richard Adams and Anne Thomas and Richard Wilson and Pramesh, \{C S\} and Ruth Langley and John Burn and Sue Campbell and Lisa Capaldi and Yvonne Carse and Durga Gadgil and Arnold Goldman and Sudeep Gupta and Gregory Leonard and Mairead Mackenzie and Mahesh Parmar and Carlo Patrono and Russell Petty and Rothwell, \{Peter M.\} and Steele, \{Robert J.c.\}",

year = "2019",

month = aug,

day = "30",

doi = "10.1016/S2468-1253(19)30289-4",

language = "English",

journal = "The Lancet Gastroenterology \& Hepatology",

issn = "2468-1253",

publisher = "Elsevier",

}

Joharatnam-hogan, N, Cafferty, F, Hubner, R, Swinson, D, Sothi, S, Gupta, K, Falk, S, Patel, K, Warner, N, Kunene, V, Rowley, S, Khabra, K, Underwood, T, Jankowski, J, Bridgewater, J, Crossley, A, Henson, V, Berkman, L, Gilbert, D, Kynaston, H, Ring, A, Cameron, D , Din, F, Graham, J, Iveson, T, Adams, R, Thomas, A, Wilson, R, Pramesh, CS, Langley, R, Burn, J, Campbell, S, Capaldi, L, Carse, Y, Gadgil, D, Goldman, A, Gupta, S, Leonard, G, Mackenzie, M, Parmar, M, Patrono, C, Petty, R, Rothwell, PM & Steele, RJC 2019, 'Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial', The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/S2468-1253(19)30289-4

TY - JOUR

T1 - Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

AU - Joharatnam-hogan, Nalinie

AU - Cafferty, Fay

AU - Hubner, Richard

AU - Swinson, Daniel

AU - Sothi, Sharmila

AU - Gupta, Kamalnayan

AU - Falk, Stephen

AU - Patel, Kinnari

AU - Warner, Nicola

AU - Kunene, Victoria

AU - Rowley, Sam

AU - Khabra, Komel

AU - Underwood, Tim

AU - Jankowski, Janusz

AU - Bridgewater, John

AU - Crossley, Anne

AU - Henson, Verity

AU - Berkman, Lindy

AU - Gilbert, Duncan

AU - Kynaston, Howard

AU - Ring, Alistair

AU - Cameron, David

AU - Din, Farhat

AU - Graham, Janet

AU - Iveson, Timothy

AU - Adams, Richard

AU - Thomas, Anne

AU - Wilson, Richard

AU - Pramesh, C S

AU - Langley, Ruth

AU - Burn, John

AU - Campbell, Sue

AU - Capaldi, Lisa

AU - Carse, Yvonne

AU - Gadgil, Durga

AU - Goldman, Arnold

AU - Gupta, Sudeep

AU - Leonard, Gregory

AU - Mackenzie, Mairead

AU - Parmar, Mahesh

AU - Patrono, Carlo

AU - Petty, Russell

AU - Rothwell, Peter M.

AU - Steele, Robert J.c.

PY - 2019/8/30

Y1 - 2019/8/30

U2 - 10.1016/S2468-1253(19)30289-4

DO - 10.1016/S2468-1253(19)30289-4

M3 - Article

SN - 2468-1253

JO - The Lancet Gastroenterology & Hepatology

JF - The Lancet Gastroenterology & Hepatology

ER -

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Access to Document

Profiles

Farhat Din

Cite this